Vaderis Therapeutics

Vaderis Therapeutics

Signal active

Organization

Contact Information

Overview

Vaderis Therapeutics is a biotechnology company in the clinical stages that specializes in the treatment of uncommon and orphan diseases.

About

Industries

Biotechnology, Life Science

Founded

2019

Employees

11-50

Headquarters locations

Switzerland, Europe

Social

N/A

Profile Resume

Vaderis Therapeutics headquartered in Switzerland, Europe, operates in the Biotechnology, Life Science sector. The company focuses on Biotechnology and has secured $148.8M in funding across 8 round(s). With a team of 11-50 employees, Vaderis Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Vaderis Therapeutics, raised $18.6M. Discover more about their projects, partnerships, and impact on our platform.

Employees

N/A

Funding Rounds

Funding rounds

1

Investors

1

Lead Investors

0

Total Funding Amount

$18.6M

Details

1

Vaderis Therapeutics has raised a total of $18.6M in funding over 1 rounds.

Announcement dateTransaction nameNumber of InvestorsMoney raisedLead Investor
2020Early Stage Venture18.6M

Investors

Vaderis Therapeutics is funded by 3 investors.

Investor NameLead InvestorFunding RoundPartners
Giovanni Mariggi-FUNDING ROUND - Giovanni Mariggi18.6M
Vaderis Therapeutics-FUNDING ROUND - Vaderis Therapeutics18.6M
Medicxi-FUNDING ROUND - Medicxi18.6M

Recent Activity

There is no recent news or activity for this profile.